Abstract:BackgroundThe significant progress of immune therapy in non-central nervous system tumors has sparked interest in employing the same strategy for adult brain tumors. However, the advancement of immunotherapy in pediatric central nervous system (CNS) tumors is not yet on par. Currently, there is a lack of comprehensive comparative studies investigating the immune ecosystem in pediatric and adult CNS tumors at a high-resolution single-cell level.MethodsIn this study, we comprehensively analyzed over 0.3 million cells from 171 samples, encompassing adult gliomas (IDH wild type and IDH mutation) as well as four major types of pediatric brain tumors (medulloblastoma (MB), ependymoma (EPN), H3K27M-mutation (DIPG), and pediatric IDH-mutation glioma (P-IDH-M)). Our approach involved integrating publicly available and newly generated single-cell datasets. We compared the immune landscapes in different brain tumors, as well as the detailed functional phenotypes of T-cell and myeloid subpopulations. Through single-cell analysis, we identified gene sets associated with major cell types in the tumor microenvironment (gene features from single-cell data, scFes) and compared them with existing gene sets such as GSEA and xCell. The CBTTC and external GEO cohort was used to analyze and validate the immune-stromal-tumor patterns in pediatric brain tumors which might potentially respond to the immunotherapy.ResultsFrom the perspective of single-cell analysis, it was observed that major pediatric brain tumors (MB, EPN, P-IDH-M, DIPG) exhibited lower immune contents compared with adult gliomas. Additionally, these pediatric brain tumors displayed diverse immunophenotypes, particularly in regard to myeloid cells. Notably, the presence of HLA-enriched myeloid cells in MB was found to be independently associated with prognosis. Moreover, the scFes, when compared with commonly used gene features, demonstrated superior performance in independent single-cell datasets across various tumor types. Furthermore, our study revealed the existence of heterogeneous immune ecosystems at the bulk-RNA sequencing level among different brain tumor types. In addition, we identified several immune-stromal-tumor patterns that could potentially exhibit significant responses to conventional immune checkpoint inhibitors.ConclusionThe single-cell technique provides a rational path to deeply understand the unique immune ecosystem of pediatric brain tumors. In spite of the traditional attitudes of “cold” tumor towards pediatric brain tumor, the immune-stroma-tumor patterns identified in this study suggest the feasibility of immune checkpoint inhibitors and pave the way for the upcoming tide of immunotherapy in pediatric brain tumors.

Heterogeneity and tumoral origin of medulloblastoma in the single-cell era

Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes

Single-cell sequencing technology in tumor research

Research progress and the prospect of using single-cell sequencing technology to explore the characteristics of the tumor microenvironment

Single‐Cell Chromatin Accessibility Analysis Reveals Subgroup‐Specific TF‐NTR Regulatory Circuits in Medulloblastoma

Heterogeneity of myeloid cells in common cancers: Single cell insights and targeting strategies

Tumor heterogeneity of acute myeloid leukemia: insights from single-cell sequencing

Medulloblastoma: Molecular understanding, treatment evolution, and new developments

Surveying Brain Tumor Heterogeneity by Single-Cell RNA-sequencing of Multi-Sector Biopsies

Human Fetal Cerebellar Cell Atlas Informs Medulloblastoma Origin and Oncogenesis

Epco-02. High Cellular Plasticity State Of Human Medulloblastoma Local Recurrence And Distant Dissemination

Research and application of single-cell sequencing in tumor heterogeneity and drug resistance of circulating tumor cells

The Unique Immune Ecosystems in Pediatric Brain Tumors: Integrating Single-Cell and Bulk RNA-sequencing

Understanding Tumor Ecosystems by Single-Cell Sequencing: Promises and Limitations

Developmental basis of SHH medulloblastoma heterogeneity

Epco-01. From Hierarchy To Geography: Multi-Clones Drive The Cellular Diversity And Evolution Of Human Medulloblastoma

Application of single-cell sequencing to the research of tumor microenvironment

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

Application and prospects of single cell sequencing in tumors

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis

Tumor immunology in the age of single-cell genomics